This week, seven Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
5 Great Dividend Mutual Funds
If you want the best of both worlds -- capital appreciation and a cash stream -- consider pursuing an equity-income strategy via one or more of these mutual funds. More
7 Biotechnology Stocks to Sell Now
The ratings of seven Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Can Pokémon and NFC Save a Struggling Nintendo?
Nintendo looks to toys and near-field communications in an attempt to revive its Wii U console with the upcoming Pokémon Rumble U. More
7 Semiconductor Stocks to Sell Now
For the current week, the overall ratings of seven Semiconductor stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
3 Diversified Telecommunication Services Stocks to Buy Now
This week, three Diversified Telecommunication Services stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
Attention, U.S. Stock Investors: Turn Your Focus to the Yen
The Japanese yen has been a leading indicator for U.S. stock market performance so far in 2013. What is the yen telling us now? More
